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~068-110[ Defibrillation Threshold~ Are Significantly
Increaaed by A Right-Sided Approach to Totally
Tranavenoua lmplantsbla Defibrillator Systems
Placement
P.A. Friedman, S. Grice, R.E. Espinosa, M.S. Stanton. Mayo Clinic,
Rochestec MN, USA
Background: Whether a totally transvenous implanteble cardiovetier defib-
rillator system (lCD) is placed via a left- or right-sided approach depends
on patient and implantor preference, venous access, and the presence of
a pre-existing pacemaker. ,The defibrillation threshold (DFT) is affected by
lead position, which in turn is determined in part by the side of access. We
reviewed our experience to determine whether the side of venous access
affects DFTs.
Methods and Ffesu/ts:Step down to failure DFTswere found in all patients
at the time of ICD implantation. Patients undergoing left-sided implantation
with two-lead systems typically had the proximal defibrillation coil in a high
SVC or left innominate vein position; right-sided implantation necessitated
lower SVC positioning of the proximal coil due to anatomical constraints.
Of 124 transvenous ICDSimplanted, 24 were excluded from analysis: 20
were active can systems, and 4 were placed in patients with pre-existing
epicardial defibrillation leads. Of the remaining 100 patients, 93 had left-
sidsd systems (32 Endotek, 61 Transvene) and 7 had right-sided systems
(all Transvene). Considering only patienta with Transvene lead systems, the
mean DFT for right-sided implantations was significantly higher than for left-
sided systems (21.0 & 5.0 J vs. 15.2 + 6.1 J, p c 0.05). When the analysis
was further restricted to patients with the same type of ICD (7219D) with
Transvene leads, the difference persisted (right-sided [n =6] 21.0 & 5.0 J,
vs. left-sided [n= 48] 15.8 + 6.1 J, p = 0.05).
Conclusion: The right-sided approach to totally transvenous ICD place-
ment using the Transvene lead system results in significantly higher DFTs
than the left-sided approach. This may bedueto anatomic constraints affact-
ing lead position. This should be considered during pm-implant assessment,
and may become more important as newer lower energy devices become
available.
I 1068-111 I EEWiyActivation~Oi,o~ingSho~~e De,iveredin
Humans. Tha Difference Between Transvenous
and ‘Active Can’ iCD Systems
G.P.Walcott, W.-C. Chau, R.E. Ideker, W.M. Smith, V.J. Plumb, G.N. Kay,
A.E. Epstein. Univemity of Alabama at Birmingham, Birmingham, AL, USA
/introduction: In humans, early activation sites (EAS) following defibrillation
shocks delivered from a transvenous (TV) lead with an eleotrcde in the RV
apex and one in the superior vena ceva arise predominantly fmm the LV
apex and anterior LV free wall. This study was designed to determine the
EAS following shocks delivered from a RV electrode to an ‘active can’ (RV-
AC) pectoral electrode. Methods: Four patients, age 60 + S, undergoing
implantation of an AC ICD were studied. A 3&pole catheter was positioned
in the LV so that poles 1–12 were in the antero-basal segment of the LV
free wall (Pos 1), poles 13-24 were at the LV apex (Pos 2) and poles 26-
36 were in the postero-basal segment of the interventricular septum (Pos
3). Elactrograms were recorded using a custom built 144-channel mapping
system. Defibrillation thresholds (D~) were determined using a step-down
technique. Resu/ta: The DFT was 420+60 V. For successful shocks, EAS
were located in Poa 3 for three patients and Pos 2 for one patient. Earliest
measured activation (EMA) occurred 417 + 463 msec after the shook. For
failed shocks, EAS were loostad at Pos 3 for two patients and Pos 2 for
1 patient; simultaneous early sites were measured at Pos 1 and Pos 3 for
one patient. EMA was recorded 215 +64 msec after the shock. Corrc/usion:
Unlike the location of EAS following shocks from a TV lead which were
located in Pos 1 and 2, EAS following shocks delivered from RV-AC are
remrdad in Pos 2 and Pos 3. This and previous work show for the first time
that in humans changes in electrode configuration can change the pattern of
activation following successful and failed defibrillation shocks.
11068-f121 peCtOrallmplentation of Automatic Defibriliatora
(iCD’S) - Generai Anesthesia vs Conacioua
Sedation
A. Bolimann, N.K. Kanuru, D. DeLurgio, P.Waker, A.R. Leon, J. Bumette,
N. Edwards, J.J. Langbarg, Cardiology Division, Emory University At/anta,
GA, USA
Miniaturization of ICD’Shas decreased the duration and morbidity of implan-
tation, making conscious sedation (SED) a reasonable alternative to general
anesthesia (GA) for this procedure. The purpese of the study was to compare
outcomes in pts having pectoral ICD implantation using GA to those treatad
with SED. Forty consecutive pts were studied. Clinical characteristics and
presenting arrhythmias of pts having ICD with GA (n = 22) were comparable
to the pts treated with SED (n = 18). All pta had the ICD placed deep to
the pactoralis muscle and all were amnestic for the procedure. There were
2 complications requiring reoperation, both in the GA group. Although the
duration of surgery was similar (78+21 min VS71 +24 rein, p= ns), thetotsl
procedure duration was longer in the GA group because of the increased
preparation time (156 + 31 min vs 122 + 36 min. p = 0.005). Pts treatad
with SED did not require admission to the Post-Anesthesia Care Unit, vs
an S9 & 34 min stay for pts subjected to GA. There were no differences in
post-operative narcotic use or the length of stay (2.5+ 1.1 VS2.5 + 1.Sdays).
Procedure-related charges were greater in the pts treated with GA ($2754 +
390 W $1472+ 213, p < 0.001).
Conclusion: Pectoral ICD implantation using SED is well tolerated and
results in a shorter, less expensive procedure.
1~[ Re,atiOnOfEpicardiai andTranSmurai
Conduction in Normai Myocardium
A. Bauer, K.D. Freigang, F,Voss, R. Becker, J.C. Senges, J. Brachmann,
W. Schoels. UniverWyof Heidelberg, Germany
Faster conduction in longitudinal (lo) than in transverse (tr) direction of my-
ocardial muscle fibers has bean demonstrated in epicardial muscle layers.
In transmural (tin) direction, muscle fibers are orientated side by side. Thus,
transmural conduction should be similar to transverse and slower than lon-
gitudinal conduction in the epicardium. Furthermore, trensmural conduction,
like transverse conduction, should be similarly less affected by the sodium-
channel blocker propafenone (P) than longitudinal conduction. In 6 normal
dogs, 6 parallel rows of 6 needle electrodes (1 cm in length, 4 bipolar eleo-
tmdes per needle, interelectrcde distance 0.2 cm, distance between needles
1 cm) were insertad into the anterior left ventricular wall, perpendicular to
the left anterior descending artery, that is, along the long axis of epi- and
endocardial fibers and along the short axis of midmyocsrdial fibers. Using
a computerized multiplexer-mapping system, 192 ekxtrograms were simul-
taneously recorded to reconstruct the spread of activation during constant
pacing at a cycle-length of 300 msec before and after application of 2 mglkg
P intravenously. Baseline values (in m/s) for 10,tr and tm conduction veloc-
ity (CV) without drug and relative changes (aCV in m/s) induoed by P are
summarized in the table below (*p <0.0510 vs tr, *P -=0.0510 vs tm, l*tr vs
tin).
CV control acv
Longitudinal 1.5 + 0.2m/s# 0.3 l0.2m/s#
Transversal 1.2 kO.2m/s* 0.2 + 0.2m/s*
Transmural 0.9+ O.lm/s** 0.1 k O.lm/s**
Conclusions: Throughout the ventricular wall, CV is faster 10to the fiber
orientation than tr and tm. These inhomogeneous conduction propertied
could facilitate the development of reentry-arrhythmias. P raducea CV more
markedly in directions longitudinal to the muscle fibera, thereby deoreaaing
these inhomogeneities. This might represent one mechanism of antiarrhyth-
mic drug action, se lmtential prerequisitea for aniaotropic reentry are being
atwlished.
/1068-1141Heart Rate Variability PrecdingSpontsneoua
Ventricular Tachycardia
V. Shusterman, L. Young, B. Aysin, V. Gottipaty, S. Fahrig, K.P. Anderson
for the ESVEM Investigators. University of Pittsburgh, Pittsbugh, PA, USA
Heart rate variability (HRV) reflects autonomic activity and changes at the
onset of ventricular tachyarrhythmias have been reported in small stud-
ies. We addressad the hypothesis that sustainad monomorphic ventricular
techycardia (VT) is preceded by an increaae in sympathetic activity ancVor
by reduced vagal tone as indicated by changes in HRV. Helter ECGS with
spontaneous VT from 49 patients (p) screened for the ESVEM trial in the
absence of antiarrhythmic drugs were studied. Spectral HRV power [very low
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(VL: 0.0033-0.04 Hz), low (L: 0.04-0.15 Hz), high (H: 0.15-0.4 Hz) and total
(T) frequency range] was eatimated by FFT over 5 min intervals and 24 hr.
Date are in ms2/Hz. Results: HRV-indices calculated over 24 hr were similar
top with recent Ml and 2x lower than in healthy subjects (T: 10084+ 9821,
VL: 1312 + 1438, L: 573 + 659, H: 194 & 245, UH: 3.8 + 3.2). L-power
averaged over 15 min intewais declined 2.5 hr before VT (p < 0.02), and
15 min before VT fell below the 24 hr-average (487 + 651 vs. 531 + 545,
p < 0.015). During 1 hr before VT heart rate (HR) increased overall (82 +
20 bpm to 89 + 19 bpm, p c 0.0009). A drop in the L-power was observed
in 52% of p, and in the majority (74%) was associated with an increase in
HR. The T, VL, H-power (in absolute or normalized units) and UH did not
change significantly before VT. Conckrsiorw L-power and UH ratio did not
increase and H-power did not decrease significantly before VT. This does
not support the hypothesis that increased sympathetic and/or decreased
parasympathetic tone precede VT. However, the reduction in L-power and
increase in HR suggest that enhanced tonic sympathetic activity (e.g. circu-
lating cetecholamines), rather than increased phasic modulation reflected by
HRV,precedes VT.
11068-115] Predi~t~r*~fTa~hyarrh~hmiasDuring
DobutemineStressTest.A Studyof 1164
PstientsWithSuspectedMyocsrdialIschemia
A. Elhendy, J.R.T.C. Roelandt, M.L. Geleijnse, R.T.van Domburg,
P.R.Nierop, G.M. El-Said, M.M. Ibrahim, M. E1-Refaee,P.M.Fioretti.
Thorexcentec Rotferdam, The Netherlands
Ventricular and supraventricular tachycardias are not uncommon during
dobutemine stress test. The aim of this study was to assess the prevalence
and predictors of these arrhythmias in patients with suspected myocardial
ischemia undergoing dobutamine stress echoeardiography.
Methods: Dobutamine (up to 40 @kg/rein) -atropine (up to 1 mg) stress
echocerdiography was performed for the detection of myocardial ischemia in
1164 patients with limited exercise capacity (age 80 + 12 years, 716 men).
623 patients (53%) had a previous myocardial infarction. A 16 segments-4
grades score model was used to assess left ventricular function where I =
normal and 4 = dyskinesis. Wall motion score index (WMSI) was derived by
the summation of wall motion score divided by 18. Ischemia was definwl as
new or worsened wall motion abnormalities.
Ffesu/ta:No.myocardial infarction or death occurred during the test. Hearl
rate and systolic blood pressure increased significantly from rest to peak
stress (72 +14 vs 134+16 beata/minute, p <0.03001 and 133+22vs 137+
30 mm Hg, p < 0.00005). Supravent~cular tachycardia (SVT) occurred in 44
patients(4%), atrial fibrillation in 14 patients (l%) and ventricular tachycerdia
(VT z 3 consecutive PVCS) in 57 patients (5%). VT was >10 beats in 7
patients. Metoprolol was used if arrhythmias persisted after discontinuation
of dobutemine. By multivariate analysis, independent predictors of VTwere a
higher resting WMSI (OR 1.8, Cl 1.1-3.2) and medication with diuretics (OR
2.6, Cl 1.4-4.5). A higher resting WMSI was the only independent predictor
of SVT (OR 1.6, Cl 1-3.1). Ischemia was not a predictor of arrhythmias.
Cone/usion:The baaeline state of myocardial function is a predictor of VT
and SVT during dobutamine stress echocardiography, Dieuretic therapy is
associated with an increased risk of VT probably due to hypokalemia that
may be additionally aggravated by dobutamine infusion.
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m1069103 Effectof ParasympatheticToneontheInternalAtrielDefibrillationThresholdin Humans
H.S. Barold, F.O.Sogade, G.R. Simons, R.A. Sorrentino, R.A. Greenfield,
J.M. Wharton. Duke University Medical CenteCDurham, NC, USA
Modulation of cardiac parasympathetic tone (PST) has beenshown tochange
atrial refractorinesswhichcould change theatnal defibrillation threshold (ADFT).
To determine the effect of reflexly increasing PST in humans, ADFT’s were
determined in6pts (49+ 23yr) undergoing electrophysiologic studiea (4atrial
flutter, 2 WPW) at baseline, during phenylephrine (PE) infusion at a dose to
increasesystolic BP ? 25 mmHganddurfng PE and0.04mg/kg atropine (A) to
block PSTand allow detection of the effect of unmodulated alpha-adrenergic
tone. ADFTs were determined with a step-up protocol beginning at 0.5 J and
incremented by O.5J with 3/3 ms biphasic shocks delivered through catheters
in the right atrial appendage (RAA) and coronary sinus, A monophasic action
potential duration (MAPD)atacmstant pacing cycle length (CL), average A-A
interval during atrial fibrillation (AF), and right atrial refractory period (RARP)
from the RAA were measured at baseline, PE and PE + A. The mean ADFT,
RARP,MAPD, NSR-CL and AA in AFare shown for each atage:
Baseline PE A + PE
ADFT (joules) 2.7* 1.2 2.5 & 0,7 2.2 * 0.9
RARP (msec) 176+ 25 1s0+35 162+ 31
MAPD (msec) 293+47 273+ 57 240+ 44~
NSR-CL (msec) 790+ 96 9S2+241s 525+ 112*
W.AF (msec) 157* 46 164+ 13 16& 14
(all p values were NS, except ‘p <0,05, “p < 0,01)
Conclusions: Increased parasympathetic tone above baseline in humans
does not aignificently disorganize AF or effect the ADFT.
-[ c,inica,Te.tin~ Ofa~Ua,~hamber~Ombined
AtrialsndVentricularDefibrillator
MS, Stanton, S.C. Hammill, J.M. Gillberg, M.L. Brown, W.H. Olson, Mayo
Clinic, RochesteGMN, USA, Medtronic, Inc., Minneapolis, MN, USA
A prototype of a new atrial and ventricular ICD that combines dual chamber
(DC) sensing and pacing, automatic mode-awitching, atrial rate stabilization
and DCtachyarrhythmia detection forventricular tachycarcfia(VT), ventricular
fibrillation (VF), atrial fibrillation (AF) and atfial flutter (AT) wee studied in 60
patients to assess pacinghensing functions, VTNF/AF/AT detection and
AT/AF therapy (50 Hz burst pacing).
Methods; The external prototype instrument was connected to catheters
(10 mm electrode spacing) in the right atrium and rtght ventricular (RV) apex
during EP studies or to the implanted RV lead and a temporary atrial lead (8
mm eladrode spacing) during ICD implant studies. A separate catheter was
used tosimulate ATand VTby pacing and to induce clinical tachyarrhythmias.
f7esu/ts: No adverse interactions between pacing and tachyarrhythmia
detection were obsewed. Cross chamber oversensing at 6 V/1,5 mS pacing
outputs was obsenred in early studies and was corrected with the addition of
a cross chamber auto-adjueting threshold. AT/AF detection was appropriate
in 62/74 induced AT/AF episodes (42 pts) and 43/47 simulated AT episodes
(33pts). VTNFdetection was appropriate in50/50 induced episodes (26 pts),
and 146/164 simulated VT episodes (45 pts). 9/19 simulated and true dual
tachycardias (DT) (Spts) were properly detected aa VTNFduring early stud-
ies; a revised detection algorithm resulted in 25/28 DTs(7 pts) being properly
detected as VTNF. Inappropriate overdetection of VTNF wea prevented in
42/57 episodea of S/l (49 pts) using DC detection enhancements. 50 Hz
burst pacing terminated 4/5 episodes of AT and 1/8 episodes of AF.Atrial rate
stabilization and automatic mode switching was successfully demonstrated
in 16 and 17 patients, respectively.
Conclusion: Sensing, detection and pacing therapies for a dual chamber
combined atrial and ventricular defibrillator were tested and improved based
on acute human testing.
-’ Timin~OfShockDuringAtrialFlutterf2ycle
PredictsOutcomeof InternalCardioversion
M.R. Karch, W.S. Ellis, F.X.Roithinger, M.D. Lesh. University of Ca/iforrria
San Francisco, San Francisco, CA, USA
Successful defibrillation requires all active wavefronts be extinguished. It
follows that very low energy shocks delivered at a time when activation is
confined to a small volume of tissue would be more effective than when a
Iargevolume of tissue is active. We hypothesized a lower energy requirement
for termination of typical atrial flutter (AFI)with shocka delivered when activa-
tiOfI k within the subeustachian isthmus (S1)versus shocka deliver~ when
activation is outside the S[, Methods: During 19 episodes of spontaneous
or induced stable AFI (CL.252 + 35 ms) in 6 pts, a four-way randomization
delivered high (mean = 6.5 + 1,9 J) vs low (mean = 0.25 + 0.16 J) energy
biphasic (3/3 ms) internal shocks (large surface area catheters in the coro-
nary sinus and lateral right atrium) when the activation wavefront was within
the SI vs outside the SI by approximately 50Y0of the AFI-CL. Synchroniza-
tion was based on recordings from a 20 polar halo catheter around the TA.
Resu/ts:The following table is based on the number of episodes tried in each
category and the outmme.
Low energy High energy p-value
lock Svnch. N Outcome N Outcome
Inside SI 6 5 SR/1 late-SR 2 2 SR NS
70 effect 4 4 SR p <0.05OutsideS1 7 1 lateSR/5AF/1I
D-value <0.05 NS
